Volitionrx Ebit vs Cost Of Revenue Analysis

VNRX Stock

USD 0.70 0.01 1.45%

Volitionrx financial indicator trend analysis is much more than just breaking down Volitionrx prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Volitionrx is a good investment. Please check the relationship between Volitionrx Ebit and its Cost Of Revenue accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Volitionrx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Volitionrx Stock please use our How to Invest in Volitionrx guide.

Ebit vs Cost Of Revenue

Ebit vs Cost Of Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Volitionrx Ebit account and Cost Of Revenue. At this time, the significance of the direction appears to have very week relationship.

The correlation between Volitionrx's Ebit and Cost Of Revenue is 0.27. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Volitionrx, assuming nothing else is changed. The correlation between historical values of Volitionrx's Ebit and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Volitionrx are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Ebit i.e., Volitionrx's Ebit and Cost Of Revenue go up and down completely randomly.

Correlation Coefficient

0.27

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Ebit

Cost Of Revenue

Cost of Revenue is found on Volitionrx income statement and represents the costs associated with goods and services Volitionrx provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most indicators from Volitionrx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Volitionrx current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Volitionrx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Volitionrx Stock please use our How to Invest in Volitionrx guide.At this time, Volitionrx's Selling General Administrative is fairly stable compared to the past year. Enterprise Value is likely to rise to about 68.4 M in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 20.5 M in 2024.

	2021	2022	2023	2024 (projected)
Research Development	15.5M	14.6M	19.6M	10.0M
Depreciation And Amortization	1.1M	1.2M	1.4M	1.5M

Research Development Depreciation And Amortization

Volitionrx fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Non Current Liabilities Total	Other Current Liab	Short Long Term Debt Total	Other Liab	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Other Current Assets	Property Plant And Equipment Gross	Intangible Assets	Property Plant Equipment	Short Term Debt
Total Assets		0.63	0.3	-0.94	-0.85	0.64	0.99	0.99	0.91	0.89	0.9	0.68	0.99	0.88	0.89	0.92	0.88	-0.68	0.85	0.83	-0.46	0.7	0.83	-0.89	0.92	0.81
Total Current Liabilities	0.63		-0.55	-0.42	-0.88	0.94	0.57	0.57	0.82	0.87	0.84	1.0	0.58	0.9	0.8	0.71	0.79	-0.16	0.58	0.58	-0.09	0.52	0.88	-0.68	0.76	0.85
Total Stockholder Equity	0.3	-0.55		-0.51	0.19	-0.48	0.37	0.37	-0.04	-0.13	-0.08	-0.49	0.36	-0.17	-0.05	0.12	-0.04	-0.54	0.17	0.15	-0.36	0.1	-0.2	-0.11	0.03	-0.2
Net Debt	-0.94	-0.42	-0.51		0.65	-0.4	-0.98	-0.98	-0.73	-0.7	-0.72	-0.47	-0.97	-0.69	-0.7	-0.84	-0.7	0.74	-0.7	-0.67	0.36	-0.54	-0.62	0.77	-0.74	-0.58
Retained Earnings	-0.85	-0.88	0.19	0.65		-0.92	-0.78	-0.78	-0.98	-0.99	-0.99	-0.92	-0.8	-0.99	-0.96	-0.85	-0.96	0.4	-0.87	-0.87	0.47	-0.81	-0.99	0.89	-0.96	-0.99
Accounts Payable	0.64	0.94	-0.48	-0.4	-0.92		0.55	0.55	0.87	0.9	0.89	0.95	0.57	0.91	0.83	0.73	0.81	-0.18	0.69	0.69	-0.34	0.7	0.92	-0.74	0.81	0.91
Cash	0.99	0.57	0.37	-0.98	-0.78	0.55		1.0	0.85	0.83	0.84	0.62	1.0	0.82	0.83	0.89	0.83	-0.71	0.79	0.76	-0.4	0.63	0.76	-0.85	0.86	0.73
Cash And Short Term Investments	0.99	0.57	0.37	-0.98	-0.78	0.55	1.0		0.85	0.83	0.84	0.62	1.0	0.82	0.83	0.89	0.83	-0.71	0.79	0.76	-0.4	0.63	0.76	-0.85	0.86	0.73
Common Stock Total Equity	0.91	0.82	-0.04	-0.73	-0.98	0.87	0.85	0.85		0.99	1.0	0.86	0.87	0.98	0.97	0.89	0.96	-0.5	0.89	0.88	-0.52	0.82	0.97	-0.92	0.97	0.97
Common Stock Shares Outstanding	0.89	0.87	-0.13	-0.7	-0.99	0.9	0.83	0.83	0.99		1.0	0.91	0.84	1.0	0.97	0.88	0.96	-0.47	0.86	0.84	-0.45	0.77	0.98	-0.91	0.97	0.97
Other Stockholder Equity	0.9	0.84	-0.08	-0.72	-0.99	0.89	0.84	0.84	1.0	1.0		0.88	0.86	0.99	0.97	0.88	0.97	-0.47	0.88	0.88	-0.5	0.81	0.98	-0.91	0.98	0.98
Total Liab	0.68	1.0	-0.49	-0.47	-0.92	0.95	0.62	0.62	0.86	0.91	0.88		0.63	0.93	0.85	0.74	0.84	-0.21	0.64	0.64	-0.15	0.56	0.91	-0.72	0.81	0.89
Total Current Assets	0.99	0.58	0.36	-0.97	-0.8	0.57	1.0	1.0	0.87	0.84	0.86	0.63		0.83	0.84	0.9	0.84	-0.7	0.8	0.78	-0.42	0.65	0.78	-0.86	0.87	0.75
Common Stock	0.88	0.9	-0.17	-0.69	-0.99	0.91	0.82	0.82	0.98	1.0	0.99	0.93	0.83		0.96	0.87	0.95	-0.45	0.82	0.81	-0.38	0.73	0.97	-0.89	0.95	0.96
Non Current Liabilities Total	0.89	0.8	-0.05	-0.7	-0.96	0.83	0.83	0.83	0.97	0.97	0.97	0.85	0.84	0.96		0.83	0.99	-0.45	0.89	0.89	-0.47	0.73	0.94	-0.89	0.98	0.96
Other Current Liab	0.92	0.71	0.12	-0.84	-0.85	0.73	0.89	0.89	0.89	0.88	0.88	0.74	0.9	0.87	0.83		0.82	-0.53	0.79	0.78	-0.49	0.74	0.85	-0.82	0.88	0.82
Short Long Term Debt Total	0.88	0.79	-0.04	-0.7	-0.96	0.81	0.83	0.83	0.96	0.96	0.97	0.84	0.84	0.95	0.99	0.82		-0.46	0.89	0.89	-0.49	0.74	0.94	-0.89	0.98	0.96
Other Liab	-0.68	-0.16	-0.54	0.74	0.4	-0.18	-0.71	-0.71	-0.5	-0.47	-0.47	-0.21	-0.7	-0.45	-0.45	-0.53	-0.46		-0.5	-0.43	0.23	-0.31	-0.38	0.74	-0.53	-0.35
Property Plant And Equipment Net	0.85	0.58	0.17	-0.7	-0.87	0.69	0.79	0.79	0.89	0.86	0.88	0.64	0.8	0.82	0.89	0.79	0.89	-0.5		0.99	-0.68	0.89	0.86	-0.86	0.93	0.87
Non Current Assets Total	0.83	0.58	0.15	-0.67	-0.87	0.69	0.76	0.76	0.88	0.84	0.88	0.64	0.78	0.81	0.89	0.78	0.89	-0.43	0.99		-0.69	0.89	0.86	-0.81	0.93	0.87
Non Currrent Assets Other	-0.46	-0.09	-0.36	0.36	0.47	-0.34	-0.4	-0.4	-0.52	-0.45	-0.5	-0.15	-0.42	-0.38	-0.47	-0.49	-0.49	0.23	-0.68	-0.69		-0.81	-0.46	0.48	-0.54	-0.54
Other Current Assets	0.7	0.52	0.1	-0.54	-0.81	0.7	0.63	0.63	0.82	0.77	0.81	0.56	0.65	0.73	0.73	0.74	0.74	-0.31	0.89	0.89	-0.81		0.82	-0.72	0.81	0.81
Property Plant And Equipment Gross	0.83	0.88	-0.2	-0.62	-0.99	0.92	0.76	0.76	0.97	0.98	0.98	0.91	0.78	0.97	0.94	0.85	0.94	-0.38	0.86	0.86	-0.46	0.82		-0.86	0.95	0.98
Intangible Assets	-0.89	-0.68	-0.11	0.77	0.89	-0.74	-0.85	-0.85	-0.92	-0.91	-0.91	-0.72	-0.86	-0.89	-0.89	-0.82	-0.89	0.74	-0.86	-0.81	0.48	-0.72	-0.86		-0.91	-0.86
Property Plant Equipment	0.92	0.76	0.03	-0.74	-0.96	0.81	0.86	0.86	0.97	0.97	0.98	0.81	0.87	0.95	0.98	0.88	0.98	-0.53	0.93	0.93	-0.54	0.81	0.95	-0.91		0.95
Short Term Debt	0.81	0.85	-0.2	-0.58	-0.99	0.91	0.73	0.73	0.97	0.97	0.98	0.89	0.75	0.96	0.96	0.82	0.96	-0.35	0.87	0.87	-0.54	0.81	0.98	-0.86	0.95

Click cells to compare fundamentals

Volitionrx Account Relationship Matchups

Volitionrx fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	21.3M	26.2M	27.5M	18.3M	28.0M	29.3M
Total Current Liabilities	3.9M	6.2M	6.5M	17.4M	31.8M	33.4M
Total Stockholder Equity	14.2M	16.3M	17.9M	(2.6M)	(7.8M)	(7.4M)
Net Debt	(13.0M)	(15.0M)	(16.6M)	(5.9M)	(14.9M)	(14.1M)
Retained Earnings	(89.8M)	(110.2M)	(137.0M)	(167.3M)	(202.6M)	(192.4M)
Accounts Payable	627.3K	1.5M	1.5M	3.0M	3.2M	3.4M
Cash	17.0M	19.4M	20.6M	10.9M	20.7M	21.8M
Cash And Short Term Investments	17.0M	19.4M	20.6M	10.9M	20.7M	21.8M
Common Stock Total Equity	35.3K	41.1K	48.6K	57.9K	66.6K	69.9K
Common Stock Shares Outstanding	39.2M	45.3M	52.7M	55.4M	71.2M	74.8M
Liabilities And Stockholders Equity	21.3M	26.2M	27.5M	18.3M	28.0M	29.3M
Other Stockholder Equity	103.9M	126.5M	154.7M	164.4M	194.4M	204.2M
Total Liab	7.1M	9.9M	9.8M	21.4M	36.7M	38.5M
Total Current Assets	17.6M	20.3M	22.0M	12.2M	21.9M	22.9M
Common Stock	41.1K	48.6K	53.8K	57.9K	81.9K	86.0K
Non Current Liabilities Total	3.2M	3.6M	3.3M	4.0M	4.8M	5.1M
Other Current Liab	2.2M	3.6M	3.7M	2.7M	3.9M	4.1M
Short Long Term Debt Total	4.1M	4.4M	4.0M	5.0M	5.9M	6.2M
Other Liab	298.0K	259.6K	253.2K	420.5K	378.4K	281.5K
Property Plant And Equipment Net	3.4M	5.5M	5.3M	6.0M	6.1M	3.1M
Non Current Assets Total	3.7M	5.8M	5.5M	6.1M	6.1M	3.8M
Non Currrent Assets Other	(3.7M)	(5.8M)	(5.5M)	(6.1M)	(1.0)	(1.05)
Other Current Assets	322.6K	879.8K	1.4M	1.2M	881.5K	474.8K
Property Plant And Equipment Gross	3.4M	5.2M	7.9M	9.3M	10.3M	10.8M
Accumulated Other Comprehensive Income	125.7K	(60.0K)	148.3K	227.1K	243.9K	256.1K
Intangible Assets	372.3K	321.6K	216.9K	110.5K	23.9K	22.7K
Property Plant Equipment	3.4M	5.5M	5.3M	5.4M	6.2M	6.5M
Short Term Debt	1.0M	1.1M	1.2M	1.6M	1.7M	1.8M
Net Tangible Assets	13.8M	16.0M	17.7M	(3.2M)	(3.7M)	(3.5M)
Current Deferred Revenue	39.3K	69.2K	12.5K	10M	23M	24.2M
Retained Earnings Total Equity	(73.7M)	(89.8M)	(110.2M)	(167.3M)	(150.5M)	(143.0M)
Capital Surpluse	85.6M	103.9M	126.5M	164.4M	189.1M	198.5M
Short Long Term Debt	647.6K	841.3K	797.9K	1.1M	1.2M	815.1K
Long Term Debt	2.2M	2.6M	2.3M	2.8M	3.6M	2.1M
Long Term Debt Total	2.4M	3.0M	3.1M	2.8M	3.2M	2.4M
Capital Lease Obligations	1.1M	993.3K	948.5K	1.1M	1.0M	1.1M
Net Invested Capital	17.0M	19.8M	21.0M	1.3M	(3.0M)	(2.8M)
Net Working Capital	13.7M	14.1M	15.5M	(5.2M)	(10.0M)	(9.5M)
Capital Stock	41.1K	48.6K	53.8K	57.9K	81.9K	58.4K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Volitionrx Stock Analysis

When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Volitionrx Ebit vs Cost Of Revenue Analysis

Ebit vs Cost Of Revenue

Ebit vs Cost Of Revenue Correlation Analysis

Correlation Coefficient

Ebit

Cost Of Revenue

Volitionrx fundamental ratios Correlations

Volitionrx Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Volitionrx fundamental ratios Accounts

Also Currently Popular

Additional Tools for Volitionrx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Other Stockholder Equity	+ 1.0	Common Stock Total Equity
Other Stockholder Equity	+ 1.0	Common Stock Shares Outstanding

Short Term Debt	- 0.99	Retained Earnings
Property Plant And Equipment Gross	- 0.99	Retained Earnings
Common Stock	- 0.99	Retained Earnings
Other Stockholder Equity	- 0.99	Retained Earnings
Common Stock Shares Outstanding	- 0.99	Retained Earnings
Common Stock Total Equity	- 0.98	Retained Earnings